AHSA1 and Miyoshi myopathy: In vitro studies identified the traditional Chinese medicine, bufalin, to exhibit cytotoxicity against MM cells and subsequent microarray analysis revealed Aha1 as the molecular target (Gu et al., 2022; Xiang et al., 2017).